Generic GLP-1 launch in US: 2027 or later
69%YES chance
Yes
69%
No
31%
Now 69.2%
Resolution
Resolves to the quarter the first FDA-approved generic GLP-1 (semaglutide or tirzepatide) launches in the US.
Source: https://www.fda.gov/
Resolves by May 23, 2027.
Recent trades
- YES@rileykim26.2 sh@ 69%18 SP
- NO@skylerunderhill86.4 sh@ 68%26 SP
- YES@kaipatel61.1 sh@ 72%43 SP
- YES@micahashworth119.8 sh@ 69%80 SP
- YES@blakevargas83.4 sh@ 64%52 SP
- NO@caseyokafor137.1 sh@ 60%50 SP
- NO@parkersantos285.2 sh@ 67%80 SP
- YES@juneyoon82.1 sh@ 77%62 SP
- YES@jordanvargas65.8 sh@ 53%34 SP
- YES@emersonhayes83.9 sh@ 74%61 SP
- YES@sashahayes36.9 sh@ 71%26 SP
- YES@parkerokafor101.8 sh@ 70%69 SP
- YES@sashahayes73.3 sh@ 66%47 SP
- YES@sashahayes134.9 sh@ 62%80 SP
- YES@tatumwalsh75.6 sh@ 56%41 SP
- YES@reesekhan166 sh@ 52%80 SP
- NO@micahashworth27.1 sh@ 44%15 SP
- NO@alexkhan157.9 sh@ 45%80 SP
Top holders
YES holders
No holders yet.
NO holders
No holders yet.
News
Refreshed every 6 hours
No news yet. Endcap's news crawler refreshes every 6 hours.
Discussion
- @blakeunderhillBlake Underhill6 days ago
small ticket, no strong view.